Who Buys Dexamethasone from India — 2257 Importers Behind a $181.4M Market
India's dexamethasone import market is served by 2257 active buyers who collectively imported $181.4M across 8,777 shipments. DR REDDYS LABORATORIES INC (UNITED STATES) leads with a 17.0% market share, followed by DR, REDDYS LABORATORIES, INC and DR.REDDY'S LABORATORIES,INC. The top 5 buyers together control 44.5% of total import value, reflecting a moderately competitive buyer landscape.
Top Dexamethasone Importers — Ranked by Import Value
DR REDDYS LABORATORIES INC (UNITED STATES) is the leading dexamethasone importer from India, holding a 17.0% share of the $181.4M market across 8,777 shipments from 2257 buyers. The top 5 buyers — DR REDDYS LABORATORIES INC (UNITED STATES), DR, REDDYS LABORATORIES, INC (UNITED STATES), DR.REDDY'S LABORATORIES,INC (UNITED STATES), SUN PHARMACEUTICAL INDUSTRIES,INC. (UNITED STATES), M/S. BAZREAL GLOBAL LTD (NIGERIA) — collectively control 44.5% of total import value.
Top Dexamethasone Buyers & Importers
Ranked by import value · 2257 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | DR REDDYS LABORATORIES INCUNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1DEXAMETHASONE SODIUM PHOSPHATE INJECTIONORJI DEXAMETHASONE B P 0 5MG TABLET | $30.9M | 5 | 17.0% |
| 2 | DR, REDDYS LABORATORIES, INCUNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1 | $23.4M | 5 | 12.9% |
| 3 | DR.REDDY'S LABORATORIES,INCUNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1 | $10.5M | 5 | 5.8% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES,INC.UNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1CIPROFLOXACIN AND DEXAMETHASONE STERILE OTIC SUSPENSION USPORJI DEXAMETHASONE B P 0 5MG TABLET | $9.3M | 5 | 5.1% |
| 5 | M/S. BAZREAL GLOBAL LTDNIGERIA CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1DEXAMETHASONE SODIUM PHOSPHATE INJECTIONDEXONA TABLETS 0.5MG 10X10 T | $6.7M | 5 | 3.7% |
| 6 | NORTHSTAR DISTRIBUTION CENTRE 8912UNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1 | $6.2M | 5 | 3.4% |
| 7 | SUN PHARMACEUTICAL INDUSTRIES INCUNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1CIPROFLOXACIN AND DEXAMETHASONE STERILE OTIC SUSPENSION USPORJI DEXAMETHASONE B P 0 5MG TABLET | $6.1M | 5 | 3.3% |
| 8 | RX CROSSROADS 3PL LLCUNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1 | $5.0M | 5 | 2.7% |
| 9 | SUN PHARMACEUTICAL INDUSTRIES INC.UNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1CIPROFLOXACIN AND DEXAMETHASONE STERILE OTIC SUSPENSION USPORJI DEXAMETHASONE B P 0 5MG TABLET | $4.2M | 5 | 2.3% |
| 10 | DR REDDYS LABORATORIES,INCUNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1DEXAMETHASONE SODIUM PHOSPHATE INJECTIONORJI DEXAMETHASONE B P 0 5MG TABLET | $4.1M | 5 | 2.3% |
| 11 | LLC SENTISS RUSRUSSIA CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1DEXAMETHASONE SODIUM PHOSPHATE INJECTIONDEXAMETHASONE - AGIO SOLUTION FOR INJECTION 4MG/ML | $3.8M | 5 | 2.1% |
| 12 | EUGIA US LLCUNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1 | $3.6M | 5 | 2.0% |
| 13 | MYLAN INSTITUTIONAL INC 2898UNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1DEXAMETHASONE MYLAN INJ 8MG/2ML 5S MYL ADEXAMETHASONE VIATRIS INJ 8MG/2ML-5S-AUS | $2.3M | 5 | 1.3% |
| 14 | MYLAN AUSTRALIAAUSTRALIA CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1DEXAMETHASONE MYLAN INJ 8MG/2ML 5S MYL ADEXAMETHASONE VIATRIS INJ 8MG/2ML-5S-AUS | $1.9M | 5 | 1.0% |
| 15 | TARO PHARMACEUTICALS INC.,CANADA CIPROFLOXACIN AND DEXAMETHASONE STERILE OTIC SUSPENSION USPCIPROFLOXACIN AND DEXAMETHASONE ( | $1.8M | 5 | 1.0% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Dexamethasone — and from which countries?
Flow of Dexamethasone exports from India: each country's share and the named importers behind the numbers
Dexamethasone — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $113.7M through 281 shipments. This represents a market share of 62.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• DR REDDYS LABORATORIES INC - $30.9M (27.2% of country's total business)
• DR, REDDYS LABORATORIES, INC - $23.4M (20.6% of country's total business)
• DR.REDDY'S LABORATORIES,INC - $10.5M (9.2% of country's total business)
• SUN PHARMACEUTICAL INDUSTRIES,INC. - $9.3M (8.2% of country's total business)
• NORTHSTAR DISTRIBUTION CENTRE 8912 - $6.2M (5.5% of country's total business)
• Rest of United States's importers - $33.4M (29.4% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $404.8K, indicating premium pricing strategy compared to the market average of $20.7K.
United States is a key market for Dexamethasone imports, representing 62.7% of total trade value.
2Ethiopia
Ethiopia emerges as the second largest importing country, achieving a total trade value of $14.6M through 0 shipments. This represents a market share of 8.0% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Ethiopia demonstrates strong market positioning with an average shipment value of $14.6M, indicating premium pricing strategy compared to the market average of $20.7K.
Ethiopia is a key market for Dexamethasone imports, representing 8.0% of total trade value.
3Nigeria
Nigeria emerges as the third largest importing country, achieving a total trade value of $11.3M through 4 shipments. This represents a market share of 6.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Nigeria has a diverse importer base, with their top importers including:
• M/S. BAZREAL GLOBAL LTD - $6.7M (59.0% of country's total business)
Key Insight: Nigeria demonstrates strong market positioning with an average shipment value of $2.8M, indicating premium pricing strategy compared to the market average of $20.7K.
Nigeria is a key market for Dexamethasone imports, representing 6.2% of total trade value.
4Russia
Russia emerges as the fourth largest importing country, achieving a total trade value of $6.5M through 27 shipments. This represents a market share of 3.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Russia has a diverse importer base, with their top importers including:
• LLC SENTISS RUS - $3.8M (59.0% of country's total business)
Key Insight: Russia demonstrates strong market positioning with an average shipment value of $239.0K, indicating premium pricing strategy compared to the market average of $20.7K.
Russia is a key market for Dexamethasone imports, representing 3.6% of total trade value.
5Australia
Australia emerges as the fifth largest importing country, achieving a total trade value of $2.7M through 53 shipments. This represents a market share of 1.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• MYLAN AUSTRALIA - $1.9M (68.6% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $51.6K, indicating premium pricing strategy compared to the market average of $20.7K.
Australia is a key market for Dexamethasone imports, representing 1.5% of total trade value.
Buyer Segment Analysis
TransData Nexus Dexamethasone buyer market intelligence
1Buyer Segment Analysis
The importation of Dexamethasone from India involves various buyer segments, each with distinct purchasing behaviors:
1. Pharmaceutical Companies: Entities like DR. REDDY'S LABORATORIES INC. and SUN PHARMACEUTICAL INDUSTRIES INC., both based in the United States, are prominent buyers. They procure Dexamethasone in bulk for manufacturing finished pharmaceutical products. Their purchasing patterns are characterized by large, consistent orders to meet production demands.
2. Distributors: Companies such as NORTHSTAR DISTRIBUTION CENTRE 8912 and RX CROSSROADS 3PL LLC, also from the United States, function as intermediaries, supplying Dexamethasone to healthcare providers and pharmacies. Their orders are substantial and regular, aligning with market demand and inventory management strategies.
3. International Buyers: M/S. BAZREAL GLOBAL LTD from Nigeria exemplifies buyers who import Dexamethasone for distribution within their national markets. Their purchasing behavior is influenced by local healthcare needs and regulatory environments, leading to variable order sizes and frequencies.
Country-Specific Import Regulations
TransData Nexus Dexamethasone buyer market intelligence
1Country-Specific Import Regulations
United States
1. Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must ensure that Dexamethasone complies with FDA regulations, including facility registration and product listing.
3. Estimated Timeline: The registration process can take several months, depending on the completeness of the application and FDA review times.
4. Import Tariff/Duty: Pharmaceutical products under HS code 30049099 are generally duty-free in the United States.
Ethiopia
1. Regulatory Authority: Ethiopian Food and Drug Authority (EFDA).
2. Import Registration Process: Importers must obtain a Certificate of Registration from the EFDA, which involves submitting product dossiers and samples.
3. Estimated Timeline: The registration process typically takes 6 to 12 months.
4. Import Tariff/Duty: Pharmaceutical imports are subject to a 5% duty under HS code 30049099.
Nigeria
1. Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).
2. Import Registration Process: Importers must register products with NAFDAC, providing comprehensive documentation and samples.
3. Estimated Timeline: The process can take 6 to 9 months.
4. Import Tariff/Duty: Pharmaceutical products under HS code 30049099 are subject to a 5% import duty.
Russia
1. Regulatory Authority: Ministry of Health of the Russian Federation.
2. Import Registration Process: Products must be registered with the Ministry, involving dossier submission and clinical trials.
3. Estimated Timeline: Registration can take up to 12 months.
4. Import Tariff/Duty: Pharmaceuticals under HS code 30049099 are generally subject to a 5% import duty.
Australia
1. Regulatory Authority: Therapeutic Goods Administration (TGA).
2. Import Registration Process: Importers must list products in the Australian Register of Therapeutic Goods (ARTG), requiring detailed documentation.
3. Estimated Timeline: The process typically takes 6 to 9 months.
4. Import Tariff/Duty: Pharmaceutical products under HS code 30049099 are generally duty-free.
Demand Drivers & Market Opportunity
TransData Nexus Dexamethasone buyer market intelligence
1Demand Drivers & Market Opportunity
The global demand for Dexamethasone is driven by several factors:
1. Disease Prevalence: Dexamethasone is widely used to treat inflammatory and autoimmune conditions. Its inclusion in treatment protocols for severe COVID-19 cases, as recommended by the World Health Organization (WHO) in 2020, has significantly increased demand.
2. Government Healthcare Programs: Many countries have expanded universal health coverage, increasing access to essential medicines like Dexamethasone. For instance, Ethiopia's Health Sector Transformation Plan (2015-2020) aimed to improve access to essential medicines, boosting demand.
3. WHO Essential Medicines List: Dexamethasone's inclusion in the WHO Essential Medicines List facilitates its procurement by international organizations and governments, ensuring its availability in public health systems.
4. Tender-Based Purchasing: Government and international health organizations often procure Dexamethasone through tenders, ensuring competitive pricing and steady demand.
With 2,257 buyers across 176 countries, the market for Dexamethasone is extensive. The repeat buyer rate of 50.7% indicates a stable demand, presenting opportunities for exporters to establish long-term relationships and expand their market presence.
Common Questions — Dexamethasone Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest dexamethasone buyer importing from India?
Based on import volume and value, DR REDDYS LABORATORIES INC (UNITED STATES) leads with $30.9M in imports and a 17.0% market share — the highest of any single dexamethasone importer. DR, REDDYS LABORATORIES, INC (UNITED STATES) and DR.REDDY'S LABORATORIES,INC (UNITED STATES) are the next largest buyers.
QHow many companies buy dexamethasone from India?
There are 2257 active dexamethasone buyers importing from India, with a combined market of $181.4M across 8,777 shipments to 176 countries. The top 5 buyers hold 44.5% of total import value, while the remaining 2252 buyers handle the other 55.5%.
QWhich countries import the most dexamethasone from India?
The top importing countries for dexamethasone from India are United States (62.7%), Ethiopia (8.0%), Nigeria (6.2%), Russia (3.6%), Australia (1.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of dexamethasone, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for dexamethasone from India?
The average import transaction value for dexamethasone from India is $20.7K, with an average unit price of $26.04 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Dexamethasone buyer market intelligence
1Buyer Segment Analysis
The importation of Dexamethasone from India involves various buyer segments, each with distinct purchasing behaviors:
1. Pharmaceutical Companies: Entities like DR. REDDY'S LABORATORIES INC. and SUN PHARMACEUTICAL INDUSTRIES INC., both based in the United States, are prominent buyers. They procure Dexamethasone in bulk for manufacturing finished pharmaceutical products. Their purchasing patterns are characterized by large, consistent orders to meet production demands.
2. Distributors: Companies such as NORTHSTAR DISTRIBUTION CENTRE 8912 and RX CROSSROADS 3PL LLC, also from the United States, function as intermediaries, supplying Dexamethasone to healthcare providers and pharmacies. Their orders are substantial and regular, aligning with market demand and inventory management strategies.
3. International Buyers: M/S. BAZREAL GLOBAL LTD from Nigeria exemplifies buyers who import Dexamethasone for distribution within their national markets. Their purchasing behavior is influenced by local healthcare needs and regulatory environments, leading to variable order sizes and frequencies.
Country-Specific Import Regulations
TransData Nexus Dexamethasone buyer market intelligence
1Country-Specific Import Regulations
United States
1. Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must ensure that Dexamethasone complies with FDA regulations, including facility registration and product listing.
3. Estimated Timeline: The registration process can take several months, depending on the completeness of the application and FDA review times.
4. Import Tariff/Duty: Pharmaceutical products under HS code 30049099 are generally duty-free in the United States.
Ethiopia
1. Regulatory Authority: Ethiopian Food and Drug Authority (EFDA).
2. Import Registration Process: Importers must obtain a Certificate of Registration from the EFDA, which involves submitting product dossiers and samples.
3. Estimated Timeline: The registration process typically takes 6 to 12 months.
4. Import Tariff/Duty: Pharmaceutical imports are subject to a 5% duty under HS code 30049099.
Nigeria
1. Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).
2. Import Registration Process: Importers must register products with NAFDAC, providing comprehensive documentation and samples.
3. Estimated Timeline: The process can take 6 to 9 months.
4. Import Tariff/Duty: Pharmaceutical products under HS code 30049099 are subject to a 5% import duty.
Russia
1. Regulatory Authority: Ministry of Health of the Russian Federation.
2. Import Registration Process: Products must be registered with the Ministry, involving dossier submission and clinical trials.
3. Estimated Timeline: Registration can take up to 12 months.
4. Import Tariff/Duty: Pharmaceuticals under HS code 30049099 are generally subject to a 5% import duty.
Australia
1. Regulatory Authority: Therapeutic Goods Administration (TGA).
2. Import Registration Process: Importers must list products in the Australian Register of Therapeutic Goods (ARTG), requiring detailed documentation.
3. Estimated Timeline: The process typically takes 6 to 9 months.
4. Import Tariff/Duty: Pharmaceutical products under HS code 30049099 are generally duty-free.
Demand Drivers & Market Opportunity
TransData Nexus Dexamethasone buyer market intelligence
1Demand Drivers & Market Opportunity
The global demand for Dexamethasone is driven by several factors:
1. Disease Prevalence: Dexamethasone is widely used to treat inflammatory and autoimmune conditions. Its inclusion in treatment protocols for severe COVID-19 cases, as recommended by the World Health Organization (WHO) in 2020, has significantly increased demand.
2. Government Healthcare Programs: Many countries have expanded universal health coverage, increasing access to essential medicines like Dexamethasone. For instance, Ethiopia's Health Sector Transformation Plan (2015-2020) aimed to improve access to essential medicines, boosting demand.
3. WHO Essential Medicines List: Dexamethasone's inclusion in the WHO Essential Medicines List facilitates its procurement by international organizations and governments, ensuring its availability in public health systems.
4. Tender-Based Purchasing: Government and international health organizations often procure Dexamethasone through tenders, ensuring competitive pricing and steady demand.
With 2,257 buyers across 176 countries, the market for Dexamethasone is extensive. The repeat buyer rate of 50.7% indicates a stable demand, presenting opportunities for exporters to establish long-term relationships and expand their market presence.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 2257 global importers of Dexamethasone identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 8,777 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 176 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
8,777 Verified Shipments
2257 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists